Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-Intermediate Risk Prostate Cancer: Improving Acute Toxicity Outcomes of Radiotherapy With the Integration of Advanced Imaging for Treatment Planning and Guidance

NCT00890006 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00890006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00890006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-Intermediate Risk Prostate Cancer: Improving Acute Toxicity Outcomes of Radiotherapy With the Integration of Advanced Imaging for Treatment Planning and Guidance
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 30, 2006
Completion date
September 30, 2027
Enrollment
99 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

low or intermediate risk prostate cancer